Sumitomo Pharma Co., Ltd.
- SEC CIK
- 0001446601
No open-market purchases or sales filed in the past year.
Current role at each company
- ROIV Roivant Sciences Ltd.10% Owneras of Jun 26, 2023
- MYOV Myovant Sciences Ltd.10% Owneras of Mar 10, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Sumitomo Pharma Co., Ltd. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ROIV Roivant Sciences Ltd.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 26, 2023 (view filing)4:05 PM ET | Jun 22 | 4 days | Sumitomo Pharma Co., Ltd. and 1 other10% Owner | SSale | −15.1M | $8.60 | −$130.0M | −17.5%71.3M after |
MYOV Myovant Sciences Ltd.
10% Owner17 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2023 (view filing)9:17 AM ET | Mar 10 | Same day | Sumitomo Pharma Co., Ltd. and 2 others10% Owner | PPurchase | +51.6M | $27.00 | +$1.39B | New position45.8M after | |
| Sep 30, 2021 (view filing)5:00 PM ET | Sep 28 | 2 days | Sumitomo Pharma Co., Ltd. and 2 others10% Owner | PPurchase | +20.7K | $22.85 | +$472.4K | 0.0%50.0M after | |
| Sep 28, 2021 (view filing)5:00 PM ET | Sep 24-27 | 4 days | Sumitomo Pharma Co., Ltd. and 2 others10% Owner | PPurchase | +84.0K | $23.87 | +$2.00M | +0.2%50.0M after | 3 lots |
| Sep 24, 2021 (view filing)5:00 PM ET | Sep 22-23 | 2 days | Sumitomo Pharma Co., Ltd. and 2 others10% Owner | PPurchase | +138.8K | $22.39 | +$3.11M | +0.3%49.9M after | 3 lots |
| Sep 22, 2021 (view filing)5:00 PM ET | Sep 20-21 | 2 days | Sumitomo Pharma Co., Ltd. and 2 others10% Owner | PPurchase | +81.3K | $22.30 | +$1.81M | +0.2%49.8M after | 2 lots |
| Sep 20, 2021 (view filing)5:00 PM ET | Sep 16-17 | 4 days | Sumitomo Pharma Co., Ltd. and 2 others10% Owner | PPurchase | +87.9K | $22.20 | +$1.95M | +0.2%49.7M after | 2 lots |
| Sep 16, 2021 (view filing)5:00 PM ET | Sep 14-15 | 2 days | Sumitomo Pharma Co., Ltd. and 2 others10% Owner | PPurchase | +161.2K | $22.03 | +$3.55M | +0.3%49.6M after | 3 lots |
| Sep 14, 2021 (view filing)5:00 PM ET | Sep 10-13 | 4 days | Sumitomo Pharma Co., Ltd. and 2 others10% Owner | PPurchase | +113.2K | $23.84 | +$2.70M | +0.2%49.5M after | 3 lots |
| Sep 10, 2021 (view filing)5:00 PM ET | Sep 8-9 | 2 days | Sumitomo Pharma Co., Ltd. and 2 others10% Owner | PPurchase | +58.9K | $25.60 | +$1.51M | +0.1%49.4M after | 2 lots |
| Sep 8, 2021 (view filing)5:00 PM ET | Sep 3-7 | 5 days | Sumitomo Pharma Co., Ltd. and 2 others10% Owner | PPurchase | +64.4K | $26.49 | +$1.71M | +0.1%49.3M after | 4 lots |